Serum Institute Gets DCGI’s Approval To Manufacture Sputnik V In India

Sputnik V in India, Vaccine Free of cost
The Russian COVID vaccine is now allowed to be manufactured in India. The vaccine will be manufactured by the Serum Institute of India (SII).

On June 4, the Drugs Controller General of India (DCGI) gave permission to officially manufacture the Sputnik V COVID vaccine in India. SII has been given the approval to manufacture Sputnik V in India for examination, test, and analysis.

SII has submitted an application to the DCGI seeking its approval on June 3. It is also the sixth confirmed pharmaceutical company that will manufacture the vaccine in India. Besides this vaccine, the Serum Institute is also manufacturing the Covishield vaccine that is used in India.

The Pune- based institute has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, from Russia to develop the vaccine.


Back in April, the Russian COVID vaccine was previously given authorisation for emergency use by the DCGI. It is the third vaccine and the first foreign-made vaccine that is approved for use in the country. Before this, the DCGI has approved Covishield and Covaxin vaccines.

Due to the rising cases of infection in the second wave, India received its first batch of Sputnik V on May 1. The imported doses of the vaccine are priced at Rs 995.40 per dose in the country.

Besides SII, the vaccine has been manufactured by five other companies. Hetero Biopharma, Gland Pharma, Panacea Biotec, Stelis Biopharma, and Virchow Biotech are other manufactures in India.

The Central government has also allowed all citizens above the age of 18 to get vaccinated in the country. Different state governments have also imposed state-wise lockdowns along with COVID-19 norms and protocols to control the rising cases.

What do you think about the Sputnik V Vaccine? Do you think it’s safe to take it? Will you and your family members take it?

Similar Posts